Müller R-U, Lianne Messchendorp A, Birn H, Capasso G, Cornec-Le Gall E, Devuyst O, Eerde A van, Guirchoun P, Harris T, Hoorn EJ, Knoers NV, Korst U, Mekahli D, Le Meur Y, Nijenhuis T, Ong AC, Sayer JA, Schaefer F, Servais A, Tesar V, Torra R, Gansevoort SBW and RT. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. KIDNEYS [Internet]. 2022 May 24 [cited 2025 Nov. 23];11(1):37-9. Available from: https://kidneysjournal.com/index.php/journal/article/view/357